Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 460

1.

CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta-analysis.

Ford N, Stinson K, Gale H, Mills EJ, Stevens W, González MP, Markby J, Hill A.

J Int AIDS Soc. 2015 Aug 7;18(1):20061. doi: 10.7448/IAS.18.1.20061. eCollection 2015.

2.

Clopidogrel and Genotyping.

Ford NF.

J Invasive Cardiol. 2015 Aug;27(8):E173-4. No abstract available.

3.

Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis.

Isaakidis P, Casas EC, Das M, Tseretopoulou X, Ntzani EE, Ford N.

Int J Tuberc Lung Dis. 2015 Aug;19(8):969-78. doi: 10.5588/ijtld.15.0123.

PMID:
26162364
4.

Long-term Virological Outcomes of First-Line Antiretroviral Therapy for HIV-1 in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.

Boender TS, Sigaloff KC, McMahon JH, Kiertiburanakul S, Jordan MR, Barcarolo J, Ford N, Rinke de Wit TF, Bertagnolio S.

Clin Infect Dis. 2015 Jul 8. pii: civ556. [Epub ahead of print]

PMID:
26157050
5.

Cochrane Column.

Wiysonge CS, Wiysonge CS, Wiysonge CS, Kredo T, Osiemo D, Boulle A, Ford N.

Int J Epidemiol. 2015 Jun;44(3):750-5. doi: 10.1093/ije/dyv111. Epub 2015 Jun 25. No abstract available.

PMID:
26111533
6.

Omega-3-Acid Ethyl Esters Block the Protumorigenic Effects of Obesity in Mouse Models of Postmenopausal Basal-like and Claudin-Low Breast Cancer.

Ford NA, Rossi EL, Barnett K, Yang P, Bowers LW, Hidaka BH, Kimler BF, Carlson SE, Shureiqi I, deGraffenried LA, Fabian CJ, Hursting SD.

Cancer Prev Res (Phila). 2015 Jun 22. [Epub ahead of print]

PMID:
26100521
7.

Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countries.

Ford N, Wiktor S, Kaplan K, Andrieux-Meyer I, Hill A, Radhakrishnan P, Londeix P, Forette C, Momenghalibaf A, Verster A, Swan T.

Int J Drug Policy. 2015 May 18. pii: S0955-3959(15)00137-1. doi: 10.1016/j.drugpo.2015.05.004. [Epub ahead of print]

PMID:
26074094
8.

Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression.

Ford N, Ludbrook G, Galletly C.

Aust N Z J Psychiatry. 2015 Jun 9. pii: 0004867415590631. [Epub ahead of print] No abstract available.

PMID:
26058787
9.

Formulating the Future Research Agenda for Postexposure Prophylaxis for HIV: Methodological Challenges and Potential Approaches.

Siegfried N, Beanland RL, Ford N, Mayer KH.

Clin Infect Dis. 2015 Jun 1;60 Suppl 3:S205-11. doi: 10.1093/cid/civ139.

PMID:
25972506
10.

Starter packs versus full prescription of antiretroviral drugs for postexposure prophylaxis: a systematic review.

Ford N, Venter F, Irvine C, Beanland RL, Shubber Z.

Clin Infect Dis. 2015 Jun 1;60 Suppl 3:S182-6. doi: 10.1093/cid/civ093.

PMID:
25972501
11.

Choice of antiretroviral drugs for postexposure prophylaxis for children: a systematic review.

Penazzato M, Dominguez K, Cotton M, Barlow-Mosha L, Ford N.

Clin Infect Dis. 2015 Jun 1;60 Suppl 3:S177-81. doi: 10.1093/cid/civ110.

PMID:
25972500
12.

Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic review.

Ford N, Shubber Z, Calmy A, Irvine C, Rapparini C, Ajose O, Beanland RL, Vitoria M, Doherty M, Mayer KH.

Clin Infect Dis. 2015 Jun 1;60 Suppl 3:S170-6. doi: 10.1093/cid/civ092.

PMID:
25972499
13.

Efficacy of HIV Postexposure Prophylaxis: Systematic Review and Meta-analysis of Nonhuman Primate Studies.

Irvine C, Egan KJ, Shubber Z, Van Rompay KK, Beanland RL, Ford N.

Clin Infect Dis. 2015 Jun 1;60 Suppl 3:S165-9. doi: 10.1093/cid/civ069.

PMID:
25972498
14.

World Health Organization Guidelines on Postexposure Prophylaxis for HIV: Recommendations for a Public Health Approach.

Ford N, Mayer KH; World Health Organization Postexposure Prophylaxis Guideline Development Group.

Clin Infect Dis. 2015 Jun 1;60 Suppl 3:S161-4. doi: 10.1093/cid/civ068.

PMID:
25972497
15.

The Strategic Use of Antiretrovirals to Prevent HIV Infection: A Converging Agenda.

Baggaley R, Doherty M, Ball A, Ford N, Hirnschall G.

Clin Infect Dis. 2015 Jun 1;60 Suppl 3:S159-60. doi: 10.1093/cid/civ091.

PMID:
25972496
16.

Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis.

Rao VB, Johari N, du Cros P, Messina J, Ford N, Cooke GS.

Lancet Infect Dis. 2015 Jul;15(7):819-24. doi: 10.1016/S1473-3099(15)00006-7. Epub 2015 May 5.

PMID:
25957078
17.

Obesity Among U.S.- and Foreign-Born Blacks by Region of Birth.

Mehta NK, Elo IT, Ford ND, Siegel KR.

Am J Prev Med. 2015 Aug;49(2):269-73. doi: 10.1016/j.amepre.2015.02.014. Epub 2015 Apr 18.

PMID:
25896192
18.

Comparative Safety and Neuropsychiatric Adverse Events Associated With Efavirenz Use in First-Line Antiretroviral Therapy: A Systematic Review and Meta-Analysis of Randomized Trials.

Ford N, Shubber Z, Pozniak A, Vitoria M, Doherty M, Kirby C, Calmy A.

J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):422-9. doi: 10.1097/QAI.0000000000000606.

PMID:
25850607
19.

CD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapy.

Peeling RW, Sollis KA, Glover S, Crowe SM, Landay AL, Cheng B, Barnett D, Denny TN, Spira TJ, Stevens WS, Crowley S, Essajee S, Vitoria M, Ford N.

PLoS One. 2015 Mar 19;10(3):e0115019. doi: 10.1371/journal.pone.0115019. eCollection 2015.

20.

Measuring absorbed dose for i-CAT CBCT examinations in child, adolescent and adult phantoms.

Choi E, Ford NL.

Dentomaxillofac Radiol. 2015;44(6):20150018. doi: 10.1259/dmfr.20150018. Epub 2015 Mar 18.

PMID:
25785822
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk